Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease.
Wang Y, Gao X, Zhang X, Xiao F, Hu H, Li X, Dong F, Sun M, Xiao Y, Ge T, Li D, Yu G, Liu Z, Zhang T.
Wang Y, et al. Among authors: dong f.
Gut Microbes. 2021 Jan-Dec;13(1):1-18. doi: 10.1080/19490976.2020.1865708.
Gut Microbes. 2021.
PMID: 33430702
Free PMC article.